Black Diamond Therapeutics Share Price Today: Live Updates & Key Insights
Black Diamond Therapeutics share price today is $2.18, up -1.86%. The stock opened at $2.15 against the previous close of $2.15, with an intraday high of $2.185 and low of $2.07.
Black Diamond Therapeutics Share Price Chart
Black Diamond Therapeutics
Black Diamond Therapeutics Share Price Performance
Black Diamond Therapeutics Institutional Holdings
Black Diamond Therapeutics Market Status
Black Diamond Therapeutics Fundamentals
Market Cap 120.22 M
PB Ratio 0.971
PE Ratio 5.7027
Enterprise Value 6.66 M
Total Assets 143.01 M
Volume 725839
Black Diamond Therapeutics Company Financials
About Black Diamond Therapeutics & investment objective
Company Information Black Diamond Therapeutics, Inc., a clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is silevertinib, a brain-penetrant epidermal growth factor receptor MasterKey inhibitor, which is in Phase 2 clinical trial for the treatment of epidermal growth factor receptor mutant non-small cell lung cancer, as well as Phase 2 clinical trial to treat glioblastoma. It is also developing BDTX-4933, a brain-penetrant RAF MasterKey inhibitor targeting KRAS, NRAS, and BRAF alterations in solid tumors that is in Phase 1 clinical trial. In addition, the company is developing BDTX-4876, a MasterKey inhibitor of oncogenic FGFR2/3 mutations with selectivity versus FGFR1/4, which is in preclinical stage. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Organisation Biotechnology
Employees 24
Industry Biotechnology
CEO Dr. Mark A. Velleca M.D., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Black Diamond Therapeutics FAQs
What is the share price of Black Diamond Therapeutics today?
The current share price of Black Diamond Therapeutics is $2.18.
Can I buy Black Diamond Therapeutics shares in India?
Yes, Indian investors can buy Black Diamond Therapeutics shares by opening an international trading and demat account with Motilal Oswal.
How to buy Black Diamond Therapeutics shares in India?
You can easily invest in Black Diamond Therapeutics shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Black Diamond Therapeutics shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Black Diamond Therapeutics.
Can I buy fractional shares of Black Diamond Therapeutics?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Black Diamond Therapeutics?
Black Diamond Therapeutics has a market cap of $120.22 M.
In which sector does Black Diamond Therapeutics belong?
Black Diamond Therapeutics operates in the Biotechnology sector.
What documents are required to invest in Black Diamond Therapeutics stocks?
To invest, you typically need:
What is the PE and PB ratio of Black Diamond Therapeutics?
The PE ratio of Black Diamond Therapeutics is 5.70 and the PB ratio is 0.97.